ARCH Venture Partners XII, LLC

Metsera, Inc. · Director, 10% Owner

ARCH Venture Partners XII, LLC is listed in public filings as director, 10 percent owner:. This ARCH Venture Partners XII, LLC insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Metsera, Inc. (MTSR), Neumora Therapeutics, Inc. Common Stock (NMRA), and Prime Medicine, Inc. (PRME). Investors use ARCH Venture Partners XII, LLC's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Metsera, Inc.MTSR$08.3M sharesOtherNov 13, 2025$838.3M shares$0.00--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Neumora Therapeutics, Inc. Common StockNMRA$16M6M sharesBuyOct 27, 2025$5.0M1.9M shares$2.61--
Prime Medicine, Inc.PRME$21M6.2M sharesBuyAug 1, 2025$10.0M3M shares$3.30--